Sharp ‘future proofs’ manufacturing with facility investment

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/klenger)
(Image: Getty/klenger)

Related tags: Sharp clinical packaging, facility, expansion, Investment, Biotech companies, Cold chain, Packaging and labeling

Sharp invests $21m to meet growing demand by expanding its capacity for packaging services at its Allentown, PA campus.

Additions to the site from the investment, which included funding from an undisclosed client,  will include the installation of vial labelers and vaporized hydrogen peroxide cold sterilization systems.

A spokesperson for Sharp told us that the company has seen increased demand for its packaging services but noted that there has been a specific interest from the biotech sector, as it has grown in recent years​.

“In expanding capacity and adding capabilities at Allentown, we are future-proofing our business in line with these [increased packaging] trends and to ensure we can meet anticipated demand in the coming years,”​ said the spokesperson.

Sharp’s Allentown campus opened as the company’s injectables center of excellence in April 2016. The site development doubled the site’s capacity for pre-filled syringe, autoinjector, and pen assembly, as well as its cold storage capacity.

Over recent years, the company has invested approximately $11m (€9.86m) in its clinical services center of excellence in Wales​, and an additional $11m was spent on bolstering its injectable and cold chain capabilities​ in the US, Belgium, and the Netherlands.

It also recently refitted its facility in Bethlehem, Pennsylvania​, as a result of a $23m investment.

The spokesperson told us that over recent years Sharp has spent over $60m​ in total, globally, to increase capacity and add clinical and commercial packaging capabilities to meet demand.

“Over the same time, we've developed a deep cross-functional expertise in the challenges of packaging biotech products, notably in the design, kitting, assembly, labeling and packaging of injectables. We want our biotech center of excellence in Allentown to continue to deliver – indeed to set the standard – for these kinds of contract services,”​ the spokesperson added.

The spokesperson added that the company has also made changes to its operational structure by establishing four different packaging centers of excellence at the Allentown campus.

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Related suppliers

Follow us


View more